Cargando…
Use of HMG-CoA Reductase Inhibitors in the HIV Population: Implications for Individualized Treatment Selection
Autores principales: | Advani, Ashish, Patel, Manish, Pichardo, Roberto V., Whitty, Yolanda, Advani, Shreena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437602/ https://www.ncbi.nlm.nih.gov/pubmed/24564807 http://dx.doi.org/10.18553/jmcp.2014.20.3.262 |
Ejemplares similares
-
Predictive Modeling
of HMG-CoA Reductase Inhibitory
Activity and Design of New HMG-CoA Reductase Inhibitors
por: Samizo, Shigeyoshi, et al.
Publicado: (2023) -
Pleiotropic effects of the HMG-CoA reductase inhibitors
por: Mihos, Christos G, et al.
Publicado: (2011) -
Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism
por: Han, Ki Hoon
Publicado: (2018) -
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
por: Noël, Martin, et al.
Publicado: (2004) -
Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients
por: Moore, Richard D., et al.
Publicado: (2011)